Blog
Articles, guides, and regulatory updates from our community.
SS-31 Peptide Research: Alpha-Synuclein & Parkinson's
New research suggests SS-31 (Elamipretide) may modulate alpha-synuclein aggregation and restore mitochondrial function in Parkinson's-related models.
By Peptide Association Research Team
SS-31 Peptide Research: Protecting the Heart from Chemo
New research suggests the mitochondria-targeted peptide SS-31 may help protect cardiac function during doxorubicin chemotherapy. Learn what the study found.
By Peptide Association Research Team
SS-31 Peptide Research: α-Synuclein & Parkinson's
New research suggests the peptide SS-31 (Elamipretide) may modulate α-synuclein aggregation and restore mitochondrial function linked to Parkinson's disease.
By Peptide Association Research Team
SS-31 Peptide Research: Protecting the Heart from Chemo
New research suggests the mitochondria-targeted peptide SS-31 may help protect cardiac function during doxorubicin chemotherapy by reducing oxidative stress.
By Peptide Association Research Team
SS-31 Peptide Research: Spinal Cord Injury Recovery
New research suggests elamipretide (SS-31) may support recovery after spinal cord injury by protecting mitochondria and reducing cell death. Learn what the study found.
By Peptide Association Research Team
SS-31 Peptide Study Shows Promise for Fat Loss Research
New research on mitochondria-targeted liposomes with SS-31 peptide demonstrates potential for enhancing thermogenesis in adipose tissue studies.
By Peptide Association Research Team